Terbinafine 250MG 30S
Ended Awarded
- Contract number
- SPE2DR26FBTCP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,697
Award facts
- Contract value 100% obligated
- $2,697.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,697.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Terbinafine 250mg tablets in a 30-count package. The delivery order, issued on November 5, 2025, with an ultimate completion date of November 6, 2025, utilizes firm fixed-price pricing with no set-aside designation. DMS Pharmaceutical Group Inc. competed in open procurement and secured this award as part of its ongoing supply relationship with the Defense Logistics Agency's Medical Supply Chain division.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) within the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The underlying IDC, designated contract SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 with an ultimate completion date of December 31, 2036, and is structured as a 30-month base period with three 30-month option periods. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors capable of supplying comprehensive pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. As a prime vendor contractor under this program, DMS Pharmaceutical Group is authorized to fulfill diverse and specialized pharmaceutical requirements for military healthcare facilities worldwide through firm fixed-price delivery orders.
Quick answers
Who was awarded contract SPE2DR26FBTCP?
SPE2DR26FBTCP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26FBTCP worth?
The government has obligated $2,697 on SPE2DR26FBTCP.
Is contract SPE2DR26FBTCP an order under another contract?
Yes. SPE2DR26FBTCP is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTCP competed?
The extent of competition for SPE2DR26FBTCP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award